Contraceptive Injections Linked to Higher Brain Tumor Risk in Women

Study finds small but significant meningioma risk with Depo-Provera use

A large U.S. study has found that women using the contraceptive depot medroxyprogesterone acetate (dMPA), commonly known as Depo-Provera, face more than double the risk of developing meningioma, a common brain tumor. While the overall risk remains low, the findings highlight the importance of awareness and individualized counseling for women considering…